Clinical trials
Essential Hypertension trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 8 |
| 2015 | 5 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 13 |
| 2023 | 9 |
| 2024 | 11 |
| 2025 | 9 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Unknown status | 11 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boryung Pharmaceutical Co., Ltd | 28 |
| Chong Kun Dang Pharmaceutical | 15 |
| Addpharma Inc. | 8 |
| Novartis Pharmaceuticals | 5 |
| Ahn-Gook Pharmaceuticals Co.,Ltd | 3 |
| Celltrion Pharm, Inc. | 3 |
| HK inno.N Corporation | 3 |
| Handok Inc. | 3 |
| Shin Poong Pharmaceutical Co. Ltd. | 3 |
| Celltrion | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 97 |
| Hypertension | 23 |
| Diabetes Mellitus, Type 2 | 4 |
| Dyslipidemias | 3 |
| Hyperlipidemias | 3 |
| Cardiovascular Diseases | 2 |
| Heart Failure | 2 |
| Angina, Stable | 1 |
| Diabetic Nephropathies | 1 |
| Edema | 1 |
Trials
Showing 76 to 97 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.